BRPI1015225A2 -
methods of identifying the ability of a stem cell to differentiate a cell into a chondrocyte, to differentiate ce = cell into a chondrocyte and to stem cell into a lesion tissue cell, to decrease chondrocyte death, to increase expression of at least a protein selected from the group consisting of tsp-2 and hb-egf from stem cell, sorting material that regulates stem cell activity and increasing expression of at least one selected from the group consisting of tsp -2 and hb-egf from stem cell and compositions for stimulating a cell to differentiate into a chondrocyte and to decrease chondrocyte death
- Google Patents
methods of identifying the ability of a stem cell to differentiate a cell into a chondrocyte, to differentiate ce = cell into a chondrocyte and to stem cell into a lesion tissue cell, to decrease chondrocyte death, to increase expression of at least a protein selected from the group consisting of tsp-2 and hb-egf from stem cell, sorting material that regulates stem cell activity and increasing expression of at least one selected from the group consisting of tsp -2 and hb-egf from stem cell and compositions for stimulating a cell to differentiate into a chondrocyte and to decrease chondrocyte death
Info
Publication number
BRPI1015225A2
BRPI1015225A2BRPI1015225ABRPI1015225ABRPI1015225A2BR PI1015225 A2BRPI1015225 A2BR PI1015225A2BR PI1015225 ABRPI1015225 ABR PI1015225ABR PI1015225 ABRPI1015225 ABR PI1015225ABR PI1015225 A2BRPI1015225 A2BR PI1015225A2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipost Co LtdfiledCriticalMedipost Co Ltd
Priority claimed from PCT/KR2010/003040external-prioritypatent/WO2010131917A2/en
Publication of BRPI1015225A2publicationCriticalpatent/BRPI1015225A2/en
BRPI1015225A2009-05-132010-05-13
methods of identifying the ability of a stem cell to differentiate a cell into a chondrocyte, to differentiate ce = cell into a chondrocyte and to stem cell into a lesion tissue cell, to decrease chondrocyte death, to increase expression of at least a protein selected from the group consisting of tsp-2 and hb-egf from stem cell, sorting material that regulates stem cell activity and increasing expression of at least one selected from the group consisting of tsp -2 and hb-egf from stem cell and compositions for stimulating a cell to differentiate into a chondrocyte and to decrease chondrocyte death
BRPI1015225A2
(en)
methods of identifying the ability of a stem cell to differentiate a cell into a chondrocyte, to differentiate ce = cell into a chondrocyte and to stem cell into a lesion tissue cell, to decrease chondrocyte death, to increase expression of at least a protein selected from the group consisting of tsp-2 and hb-egf from stem cell, sorting material that regulates stem cell activity and increasing expression of at least one selected from the group consisting of tsp -2 and hb-egf from stem cell and compositions for stimulating a cell to differentiate into a chondrocyte and to decrease chondrocyte death
composition, methods for treating a condition, for delaying the onset of a condition, for reducing an individual's risk of acquiring a condition, and for altering the expression of one or more genes in an individual
compound, pharmaceutical composition, method for treating a pi3k-related disease or disorder in an individual in need thereof, method for treating a mtor-mediated disease, method for treating both pi3k and hdac-mediated diseases
Aqueous composition comprising approximately 18% w / v concentration, where at least 95% of the proteins are igg; improved method to prepare said composition.
composition, microparticle, plurality of microparticles, and methods for treating a disease, for making a composition, and for modulating the release of a protein
vaccine, method for dispensing an antigen to a mammal, composition, methods for dispensing siren within professional antigen presenting cells, for inhibiting proliferation of tumor cells, and for dispensing a nucleic acid to a cell.
compound, pharmaceutical composition, use of a compound, method of treating an individual suffering from a pathological condition or disease and combination product
bispecific antigen binding protein, method for preparing a bispecific antigen binding protein, host cell, pharmaceutical composition, use of the bispecific antigen binding protein and method for treating a patient.
anti-alpha-synuclein antibodies and fragments thereof, their uses and methods of preparation, composition comprising them, polynucleotide encoding them, vector comprising such polynucleotide, host cell comprising such vector, as well as in vitro kit and methods for the prognosis and monitoring of a synucleinopathic disease
Soluble fraction of a protein hydrolyzate composition, method for increasing cholecystokinin release activity of a cell, method for promoting satiety in an individual and food product
specific binding molecule cultured against human anx-a1 protein, hybridoma cell line, pharmaceutical composition, use of the specific binding molecule and method for treating a t lymphocyte mediated disease in an individual in need thereof
COMPOSITIONS CONTAINING PROBIOTICS AND COMPLEX OF BEE POULTRY / CLAY, METHOD OF THEIR PREPARATION AND THEIR APPLICATION IN FOOD AND THERAPY
Legal Events
Date
Code
Title
Description
B08F
Application fees: dismissal - article 86 of industrial property law
B08K
Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)
Free format text:
EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.